Loading...

Intellectia LogoIntellectia
AI Trading Bot
Features
Markets
News
Resources
Pricing
Get Started
  1. Home
  2. Stock
  3. CNTY
CNTY logo

CNTY Should I Buy

-
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
$
0.000
0.000(0.000%)
At close
0.000(0.000%)Aft-market
ET
OverviewStock Price PredictionTechnicalValuationFinancialsEarningsShould I BuyNews & Events
an image of Intellectia Logoan image of Intellectia

Most Trusted AI Platform for Winning Trades

TwitterYoutubeQuoraDiscordLinkedinTelegram

Copyright © 2026 Intellectia.AI. All Rights Reserved.

Company

  • Home
  • Contact
  • About Us
  • Press
  • Privacy
  • Terms of Service
  • Service Terms of Use

Resources

  • Blog
  • Tutorial
  • Help Center
  • Affiliate Program

Markets

  • Market Analysis
  • Crypto
  • Featured Screeners
  • AI Earnings Calendar
  • Market Movers
  • Stock Monitor
  • Economic Calendar
  • All US Stocks
  • All Cryptos

Tools

  • Dividend Calculator
  • Dividend Yield Calculator
  • Options Profit Calculator

Features

  • QuantAI Alpha Pick
  • SwingMax Portfolio
  • Swing Trading
  • AI Stock Picker
  • Whales Auto Tracker
  • Daytrading Center
  • Patterns Detection
  • AI Screener
  • Financial AI Agent
  • Backtesting Playground
  • AI Earnings Prediction
  • Stock Monitor
  • Technical Analysis

News

  • Overview
  • Top News
  • Daily Market Brief
  • Earnings Analysis
  • Newswire
  • Stock News
  • Crypto News
  • Institution News
  • Congress News
  • Monitor News

Compare

  • TradingView
  • SeekingAlpha
Intellectia

Should You Buy Century Casinos Inc (CNTY) Today? Analysis, Price Targets, and 2026 Outlook.

Conclusion
Hold
Latest Price
1.290
1 Day change
-3.73%
52 Week Range
2.850
Analysis Updated At
2026/07/03
Should I buy Analysis is updated weekly. For real time "Should I Buy" analysis, please sign up to get free answers.

Century Casinos Inc (CNTY) is not a good buy right now for a beginner, long-term investor with $50,000-$100,000 to deploy. The stock is trading in a weak technical downtrend, there are no bullish proprietary signals, no recent news catalyst, and no meaningful positive insider, hedge fund, congress, or analyst momentum provided. The best direct read from the data is to hold off and not buy now.

Technical Analysis

CNTY is technically weak. MACD is below zero and still contracting, which supports bearish momentum. The SMA stack is bearish with SMA_200 > SMA_20 > SMA_5, showing the broader trend remains down. RSI_6 at 31.575 is near oversold but not yet a strong reversal signal. Price at 1.26 is sitting right at the S1 support level of 1.261, with the next support at 1.211. Resistance is overhead at 1.341, 1.421, and 1.471. The short-term pattern data suggests only modest upside probabilities, but the broader setup still favors caution over immediate entry.

Options Data

Bullish
Open Interest Put-Call Ratio
Bullish
Option Volume Put-Call Ratio

Options sentiment is not showing active bearish or bullish conviction based on the provided ratios, but the setup is thin and unhelpful for a strong buy case. Open interest put-call ratio is 0.0, option volume put-call ratio is 0.0, and today’s volume is 0, which means there is no meaningful options activity to confirm directional sentiment. Implied volatility is extremely high at 608.59 with IV percentile at 100, suggesting options are very expensive and the market is pricing in large uncertainty. That is not a favorable signal for a beginner long-term buyer.

Technical Summary

StrongSellSellNeutralBuyStrongBuydotted line Image
Sell
11
Buy
1

Positive Catalysts

  • No news in the recent week, so there are no clear event-driven catalysts. The only mild positive is that price is hovering near support, which could attract short-term buyers if it holds. The stock trend model also shows a possible modest upside over the next week and month, but this is not strong enough to outweigh the broader weakness.

Neutral/Negative Catalysts

  • There has been no recent news to improve sentiment. Hedge funds are neutral, insiders are neutral, and there is no recent congress trading data. The technical trend is bearish, there is no AI Stock Picker signal, and no recent SwingMax signal. High implied volatility also signals uncertainty rather than conviction. Overall, there is no strong catalyst to justify buying now.

Financial Performance

Financial snapshot data was not available due to an error, so latest quarter revenue or earnings growth cannot be confirmed from the provided information. Because the latest quarter season is missing, there is no financial evidence here to support a long-term buy decision.

Growth

Profitability

Efficiency

Analyst Ratings and Price Target Trends

No analyst rating or price target trend was provided, so there is no visible Wall Street upgrade/downgrade momentum to support the stock. Based on the available data, Wall Street appears neutral to cautious rather than bullish. Pros: the stock is near support and has speculative upside potential. Cons: bearish trend, no bullish signal, no catalyst, and no confirmed analyst support.

Wall Street analysts forecast CNTY stock price to rise
2 Analyst Rating
Wall Street analysts forecast CNTY stock price to rise
2 Buy
0 Hold
0 Sell
Moderate Buy
Current: 1.340
sliders
Low
4
Averages
4
High
4
Current: 1.340
sliders
Low
4
Averages
4
High
4
Piper Sandler
NULL
to
Overweight
upgrade
$2 -> $4
AI Analysis
2026-01-20
Reason
Piper Sandler
Price Target
$2 -> $4
AI Analysis
2026-01-20
upgrade
NULL
to
Overweight
Reason
Piper Sandler raised the firm's price target on Century Therapeutics to $4 from $2 and keeps an Overweight rating on the shares. The firm notes Century plans to submit an IND for CNTY-813 this year and report initial data in 2027. Piper estimates Century now hold pro forma cash of about $267M to fund operations into Q1 2029.
Clear Street
Bill Maughan
Buy
downgrade
$8
2026-01-08
Reason
Clear Street
Bill Maughan
Price Target
$8
2026-01-08
downgrade
Buy
Reason
Clear Street analyst Bill Maughan lowered the firm's price target on Century Therapeutics to $6.60 from $8 and keeps a Buy rating on the shares. The private placement brings the runway out to 1Q29, allowing for development of a fuller picture of the true potential of lead asset CNTY-813 before needing additional capital, the analyst tells investors in a research note. The firm added that it is reducing its price target on dilution from the raise, offset by increased pipeline likelihood of success and peak sales.
Unlock Full Analyst Thesis, Get the complete breakdown of rating reason for CNTY
Unlock Now

People Also Watch